• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Company Encyclopedia
View More
name
Peptidream Inc.
4587.JP
Shareholder
Ownership%OwnedShare ChgReport Date
No Data
News
View More

Peptidream And Alnylam Announce Achievement Of Key Milestone In Sirna Conjugate Discovery Collaboration

Dec 18 (Reuters) - PeptiDream Inc (4587.T) :* PEPTIDREAM AND ALNYLAM ANNOUNCE ACHIEVEMENT OF KEY MILESTONE IN SIRNA CONJUGATE DISCOVERY COLLABORATION DEMONSTRATING PEPTIDE-LIGAND MEDIATED TARGETED SIRNA DELIVERY TO SPECIFIC EXTRAHEPATIC TISSUES Source text: Further company coverage: (4587.T)

Reuters·12/18/2025 20:08
US
ALNY
-0.02%
JP
4587
0.00%
Reuters·12/18/2025 20:08
US
ALNY
-0.02%
JP
4587
0.00%

Peptidream Announces Pre-Clinical Results Of Oral Il-17A And Il-17F Inhibitor

Dec 17 (Reuters) - PeptiDream Inc (4587.T) :* PEPTIDREAM ANNOUNCES PROMISING PRE-CLINICAL RESULTS OF PROPRIETARY ORAL IL-17A AND IL-17F DUAL INHIBITOR WITH BIOLOGIC-LIKE EFFICACY FOR THE TREATMENT OF PSORIASIS Source text: Further company coverage: (4587.T)

Reuters·12/17/2025 21:21
JP
4587
0.00%
Reuters·12/17/2025 21:21
JP
4587
0.00%
© 2025 Longbridge|Disclaimer